- Home
- Publications
- Publication Search
- Publication Details
Title
Galectins as Cancer Biomarkers
Authors
Keywords
-
Journal
Cancers
Volume 2, Issue 2, Pages 592-610
Publisher
MDPI AG
Online
2010-04-20
DOI
10.3390/cancers2020592
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- POTENTIAL DIAGNOSTIC MARKERS IN NODULAR LESIONS OF THE THYROID GLAND: AN IMMUNOHISTOCHEMICAL STUDY
- (2012) Marie Rydlova et al. BIOMEDICAL PAPERS-OLOMOUC
- Increased Serum 90K and Galectin-3 Expression Are Associated with Advanced Stage and a Worse Prognosis in Diffuse Large B-Cell Lymphomas
- (2009) Seok Jin Kim et al. ACTA HAEMATOLOGICA
- Regulation of Prostate Cancer Progression by Galectin-3
- (2009) Yi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Galectin-3 Increases Gastric Cancer Cell Motility by Up-regulating Fascin-1 Expression
- (2009) Seok–Jun Kim et al. GASTROENTEROLOGY
- Epidermal Growth Factor Receptor Expression in Serous Ovarian Carcinoma: An Immunohistochemical Study With Galectin-3 and Cyclin D1 and Outcome
- (2009) Hermann Brustmann INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients
- (2009) Pierre Vereecken et al. MELANOMA RESEARCH
- Roles of galectins in infection
- (2009) Gerardo R. Vasta NATURE REVIEWS MICROBIOLOGY
- Molecular Phenotyping of Thyroid Tumors Identifies a Marker Panel for Differentiated Thyroid Cancer Diagnosis
- (2008) Sam M. Wiseman et al. ANNALS OF SURGICAL ONCOLOGY
- PROTEOMIC ANALYSIS TO IDENTIFY BIOMARKER PROTEINS IN PANCREATIC DUCTAL ADENOCARCINOMA
- (2008) Jun Chul Chung et al. ANZ JOURNAL OF SURGERY
- Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast
- (2008) SERGIO FERNANDEZ-AGUILAR et al. APMIS
- Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study
- (2008) V. Balan et al. CANCER RESEARCH
- Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-γ, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma
- (2008) Ying Y Liu et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Biomarker panel diagnosis of thyroid cancer: a critical review
- (2008) Obi L Griffith et al. Expert Review of Anticancer Therapy
- Low Expression of Bax Predicts Poor Prognosis in Resected Non-small Cell Lung Cancer Patients with Non-squamous Histology
- (2008) S. H. Jeong et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Galectin-3 in urine of cancer patients: stage and tissue specificity
- (2008) Kiruthika Balasubramanian et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study
- (2008) Armando Bartolazzi et al. LANCET ONCOLOGY
- Galectin-3 Upregulation During Tumor Progression in Head and Neck Cancer
- (2008) Sven Saussez et al. LARYNGOSCOPE
- Galectin-3: A useful biomarker for differential diagnosis of brain tumors
- (2008) Sung-Hye Park et al. NEUROPATHOLOGY
- Serum Galectin-1 and Galectin-3 Levels in Benign and Malignant Nodular Thyroid Disease
- (2008) Sven Saussez et al. THYROID
- The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy
- (2007) Sven Saussez et al. ORAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started